SINA LINMAN: Open Payments
NPI 1609946243 · COUNCIL BLUFFS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 11 payments from 7 companies in 2025. Trend: 2023 $555 · 2024 $435 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $120 |
| SK Life Science, Inc. | 1 | $75 |
| Supernus Pharmaceuticals, Inc. | 3 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Novo Nordisk Inc | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $17 |
Products named: Symbravo, XCOPRI, Qelbree, CAPLYTA, Rybelsus, HETLIOZ, VRAYLAR.
Industry payments across IA — which companies pay providers there.
